MPP’s contribution to the global response to COVID-19

From the outset of the COVID-19 outbreak, MPP realised that equitable access to treatments would be essential in the fight against this global threat. MPP issued a statement on 5 February 2020 offering its expertise to support access to treatment through its voluntary licensing mechanism in low- and middle- income countries.

On 31 March 2020, MPP’s Board decided to expand MPP’s mandate to include any health technology that could contribute to the global response to COVID-19 and where licensing could facilitate innovation and accelerate access.

International Goals

The coronavirus pandemic presents an opportunity for the world to act in solidarity and turn this crisis into an impetus to achieve the UN Sustainable Development Goals.

MPP’s activities and contributions:

Access Useful Resources

MPP Logo

Subscribe to our Newsletter

Founded & funded by

Unitaid Logo

Other funders